Quick Overview: Guest: Rosalyn Adigun, M.D., Pharm.D. Host: S. Allen Luis, M.B.B.S., Ph.D. In this episode of Mayo Clinic's “Interviews With the ... In this Mayo Clinic video, Martha Grogan, M.D., Mayo Clinic cardiologist, provides a description of wild-type or In this JACC Journal Club session, we explore groundbreaking research on novel therapies for
Treatment And Management Of Transthyretin - Detailed Overview & Context
Guest: Rosalyn Adigun, M.D., Pharm.D. Host: S. Allen Luis, M.B.B.S., Ph.D. In this episode of Mayo Clinic's “Interviews With the ... In this Mayo Clinic video, Martha Grogan, M.D., Mayo Clinic cardiologist, provides a description of wild-type or In this JACC Journal Club session, we explore groundbreaking research on novel therapies for A Mayo Clinic panel comprising Drs Martha Grogan, Julie Rosenthal, and Melissa Lyle discuss new and investigational A disheartening cardiovascular disorder, ATTR-CM is a progressive, underdiagnosed, potentially fatal disease in which amyloid ... Dr. Gonzalo Barge-Caballero, a Cardiologist from the Universidad de A Coruña, in Coruña, Spain, and the Instituto de Salud ...
Marcus Anthony Urey, MD, University of California, San Diego, CA, comments on the the multidisciplinary Richard Cheng, MD, MSc Associate Professor of Medicine; Attending Physician University of Washington. This content has been developed for healthcare professionals only. Patients who seek health information should consult with their ... YouTube/Podcast Description: This content has been developed for healthcare professionals only. Patients who seek health ... Joban Vaishnav, MD, presented at Johns Hopkins PM&R Grand Rounds in June 2025 on Keyur B. Shah, MD, Virginia Commonwealth University Health, discusses the approval of acoramidis for the
Amyloidosis is a serious condition caused by the buildup of abnormal, insoluble amyloid fibrils within the tissues and organs. CardioNerds (Drs. Rick Ferraro ( and Georgia Vasilakis Tsatiris ( ) discuss ...
